Literature DB >> 9155648

Mouse hepatitis viral infection induces an extrathymic differentiation of the specific intrahepatic alpha beta-TCRintermediate LFA-1high T-cell population.

L Lamontagne1, E Massicotte, C Page.   

Abstract

Mouse hepatitis virus type 3 (MHV3), a coronavirus, is an excellent model for the study of thymic and extrathymic T-cell subpopulation disorders induced during viral hepatitis. It was recently reported that, in addition to the intrathymic T-cell differentiation pathway, an extrathymic differentiation pathway of alpha beta-T-cell receptor (TCR) T lymphocytes exists in the liver, and becomes important under pathological situations such as autoimmune diseases, malignancies or hepatic bacterial infections. In the present study, we compared the phenotypes of resident hepatic, splenic or thymic T-cell subpopulations during the acute viral hepatitis induced by HMV3 in susceptible C57BL/6 mice. The number of liver-resident mononuclear cells (MNC) increased during the viral infection, while cellularity decreased. Single positive (SP) CD4+ cells strongly increased in both the liver and thymus, while double positive (DP) (CD4+ CD8+) cells, present in the liver and thymus of mock-infected mice, decreased in C57BL/6 mice during the viral infection. A shift of alpha beta-TCRintermediate T cells toward alpha beta-TCRhigh was evidenced in the liver and thymus of infected mice, but not in the spleen. The few alpha beta-TCRint double negative (DN) (CD4-CD8-) cells also decreased following viral infection. alpha beta-TCRint or high lymphocytes expressing high levels of leucocyte function antigen-1 (LFA-1) increased in the liver of MHV3-infected mice. In addition, liver-resident T cells expressed strongly the CD44 (Pgp-1) activation marker, suggesting that they were either activated or antigen experienced during the viral infection. No significant change in T-cell subpopulations was detected in the spleen, suggesting that MHV3 infection could induce an early in situ differentiation of resident hepatic T cells rather than a recruitment of lymphocytes from peripheral lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155648      PMCID: PMC1456597          DOI: 10.1111/j.1365-2567.1997.00402.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  40 in total

1.  Thymus-derived lymphocytes: their distribution and role in the development of peripheral lymphoid tissues of the mouse.

Authors:  M C Raff; J J Owen
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

2.  Immunopathology of mouse hepatitis virus type 3 infection. III. Clinical and virologic observation of a persistent viral infection.

Authors:  C L Prévost; J L Virelizier; J M Dupuy
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

3.  Host age and genotypic effects on enterotropic mouse hepatitis virus infection.

Authors:  S W Barthold
Journal:  Lab Anim Sci       Date:  1987-02

Review 4.  The biology and pathogenesis of coronaviruses.

Authors:  H Wege; S Siddell; V ter Meulen
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

5.  Adult mouse hepatocytes in primary monolayer culture express genetic resistance to mouse hepatitis virus type 3.

Authors:  H Arnheiter; T Baechi; O Haller
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

6.  Susceptibility/resistance to mouse hepatitis virus strain 3 and macrophage procoagulant activity are genetically linked and controlled by two non-H-2-linked genes.

Authors:  V J Dindzans; E Skamene; G A Levy
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

7.  Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo.

Authors:  J A Byrne; M B Oldstone
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

8.  Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.

Authors:  M Pope; S W Chung; T Mosmann; J L Leibowitz; R M Gorczynski; G A Levy
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

Review 9.  The molecular biology of coronaviruses.

Authors:  L S Sturman; K V Holmes
Journal:  Adv Virus Res       Date:  1983       Impact factor: 9.937

10.  Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice.

Authors:  G A Levy; J L Leibowitz; T S Edgington
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

View more
  5 in total

1.  Intrahepatic endothelial and Kupffer cells involved in immunosuppressive cytokines and natural killer (NK)/NK T cell disorders in viral acute hepatitis.

Authors:  A Jacques; C Bleau; J-P Martin; L Lamontagne
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

2.  Alterations induced by chronic stress in lymphocyte subsets of blood and primary and secondary immune organs of mice.

Authors:  L Domínguez-Gerpe; M Rey-Méndez
Journal:  BMC Immunol       Date:  2001-07-31       Impact factor: 3.615

3.  Recovery from mouse hepatitis virus infection depends on recruitment of CD8(+) cells rather than activation of intrahepatic CD4(+)alphabeta(-)TCR(inter) or NK-T cells.

Authors:  L Lamontagne; S Lusignan; C Page
Journal:  Clin Immunol       Date:  2001-12       Impact factor: 3.969

4.  Macrophage interleukin-6 and tumour necrosis factor-alpha are induced by coronavirus fixation to Toll-like receptor 2/heparan sulphate receptors but not carcinoembryonic cell adhesion antigen 1a.

Authors:  Alexandre Jacques; Christian Bleau; Claire Turbide; Nicole Beauchemin; Lucie Lamontagne
Journal:  Immunology       Date:  2009-08-04       Impact factor: 7.397

5.  A synergistic interferon-gamma production is induced by mouse hepatitis virus in interleukin-12 (IL-12)/IL-18-activated natural killer cells and modulated by carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1a receptor.

Authors:  Alexandre Jacques; Christian Bleau; Claire Turbide; Nicole Beauchemin; Lucie Lamontagne
Journal:  Immunology       Date:  2008-12-18       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.